| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |